Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease

Autor: Chikamatsu, Mayuko, Watanabe, Hiroshi, Shintani, Yuhi, Murata, Ryota, Miyahisa, Masako, Nishinoiri, Ayano, Imafuku, Tadashi, Takano, Mei, Arimura, Nanaka, Yamada, Kohichi, Kamimura, Miya, Mukai, Baki, Satoh, Takao, Maeda, Hitoshi, Maruyama, Toru

Publikováno v: In Journal of Controlled Release March 2023 355:42-53

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

α 1 -Acid Glycoprotein Attenuates Adriamycin-Induced Nephropathy via CD163 Expressing Macrophage Induction.

Autor: Fujimura R; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.; Program for Leading Graduate Schools 'HIGO (Health life science: Interdisciplinary and Global Oriented) Program,' Kumamoto University, Kumamoto, Japan., Watanabe H; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Nishida K; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Fujiwara Y; Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan., Koga T; Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan., Bi J; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.; Program for Leading Graduate Schools 'HIGO (Health life science: Interdisciplinary and Global Oriented) Program,' Kumamoto University, Kumamoto, Japan., Imafuku T; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.; Program for Leading Graduate Schools 'HIGO (Health life science: Interdisciplinary and Global Oriented) Program,' Kumamoto University, Kumamoto, Japan., Kobayashi K; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Komori H; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Miyahisa M; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Maeda H; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Tanaka M; Department of Nephrology, Akebono Clinic, Kumamoto, Japan., Matsushita K; Department of Nephrology, Akebono Clinic, Kumamoto, Japan., Wada T; Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan., Fukagawa M; Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Kanagawa, Japan., Maruyama T; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.

Publikováno v: Kidney360 [Kidney360] 2020 Mar 24; Vol. 1 (5), pp. 343-353. Date of Electronic Publication: 2020 Mar 24 (Print Publication: 2020).